Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement
about
PET Scans for Staging and Restaging in Diffuse Large B-Cell and Follicular LymphomasState-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PETMetabolic Tumor Volume Measured by F-18 FDG PET/CT can Further Stratify the Prognosis of Patients with Stage IV Non-Small Cell Lung Cancer.Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B-cell lymphoma.The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD)Clinical significance of standardized uptake value and maximum tumor diameter in patients with primary extranodal diffuse large B cell lymphoma.Baseline total lesion glycolysis measured with (18)F-FDG PET/CT as a predictor of progression-free survival in diffuse large B-cell lymphoma: a pilot study.Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL.State-of-the-Art Research on "Lymphomas: Role of Molecular Imaging for Staging, Prognostic Evaluation, and Treatment Response".Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma.PET/CT in malignant lymphoma: basic information, clinical application, and proposal.Current role of FDG PET/CT in lymphoma.Predictive value of F-18 FDG PET/CT quantization parameters in diffuse large B cell lymphoma: a meta-analysis with 702 participants.FDG PET/CT imaging as a biomarker in lymphoma.Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma.Utility of interim and end-of-treatment PET/CT in peripheral T-cell lymphomas: A review of 124 patients.Predictive value of (18)F-FDG PET/CT in adults with T-cell lymphoblastic lymphoma: post hoc analysis of results from the GRAALL-LYSA LLO3 trial.Prospective Study of 3'-Deoxy-3'-18F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell Lymphoma.Prognostic Value of Metabolic Tumor Volume Estimated by (18) F-FDG Positron Emission Tomography/Computed Tomography in Patients with Diffuse Large B-Cell Lymphoma of Stage II or III Disease.Prognosis in diffuse large B-cell lymphoma: the picture continues to come into focus.Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients.Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on ¹⁸F-FDG PET/CT in patients with extranodal NK/T-cell lymphoma.Tumor and bone marrow uptakes on [18F]fluorodeoxyglucose positron emission tomography/computed tomography predict prognosis in patients with diffuse large B-cell lymphoma receiving rituximab-containing chemotherapy.Prognostic significance of total metabolic tumor volume on 18F-fluorodeoxyglucose positron emission tomography/ computed tomography in patients with diffuse large B-cell lymphoma receiving rituximab-containing chemotherapy.Combination of baseline FDG PET/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma.Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma.FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS study.Baseline and ongoing PET-derived factors predict detrimental effect or potential utility of 18F-FDG PET/CT (FDG-PET/CT) performed for surveillance in asymptomatic lymphoma patients in first remission.Early interim PET/CT predicts post-treatment response in diffuse large B-cell lymphoma.Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma.Prognostic value of Waldeyer's ring involvement of diffuse large B-cell lymphoma treated with R-CHOP.Correlation sometimes implies causation: possible roles of correlation analysis between 18 fluorine-fluorodeoxyglucose positron emission tomography/computed tomography and thymic epithelial neoplasms.Limitation in the assessment of baseline lymphomatous bone marrow involvement by FDG-PET/CT scan.Posttransplant Lymphoproliferative Disorder after Cardiac Transplantation in Children: Life Threatening Complications Associated with Chemotherapy Combined with Rituximab
P2860
Q26752284-125AA66E-FA18-4BFC-B201-82092F40DAB5Q27694674-3DCD6CDF-60B8-43C0-9DC4-2DEE0B5A1A77Q33704656-4D0FB50A-AD57-4013-A115-5AE844A98750Q35439403-A3AED549-B441-41AB-B199-DF35FFAA6EBFQ36104671-3F6C3E6A-C96A-45ED-97C5-5C52FA0A255EQ36297659-C499F16F-08D2-453D-A29E-F2D7A80DD8DBQ36769240-13F6E610-AF55-4590-9AB9-CAA197B0D95CQ36897012-A704EA87-6E1D-4FF9-850E-1982C2BC718EQ37144956-51C6180B-BB0C-4D30-AE2D-18EBC07A7114Q37240835-433E994F-DE35-4CF2-B9D6-4291ECD1A971Q37696341-527535E6-7C92-4DA6-AE2B-A89C008EEE9AQ38142869-8469FF72-D172-4BD5-A02B-C22E23E7EB47Q38187365-08D1B13A-A97A-497F-85F5-06330AE23911Q38289458-D47C906E-6E1C-46E4-8768-D3CE83D91953Q38312367-0E206B50-AD78-4931-97D1-18D6350F5B4EQ38446917-7F7A1124-66A4-4D3B-9BF4-21A400405107Q38552173-D9D5BDD4-0DC7-42C8-A3E0-0E0BE23361ADQ38667096-EF9B9308-934F-4000-BE9C-B765A2BB2967Q40929539-85EE4045-C7D5-4F6B-838E-FE27A9EA67A4Q42842196-4A60AB60-8870-46A0-B209-50724E47C808Q43801754-AE5E4F53-FA4D-4EF4-87DF-375DC956DEFFQ44021769-5516B977-B5B4-4461-B233-CAE2D4B45782Q45849759-1CE22EDA-ABF7-43FD-9CCD-7D63C2E5CB0AQ46167676-E86D81D7-71B4-4BCD-B05E-40E8921A3A78Q47108600-26677371-8ED3-46FB-84A6-A9F4CA143A25Q48222205-11A8AB4E-1E89-432B-A4B8-3656E475C694Q49827199-0E408933-B1B1-4070-8724-2489F5C292CFQ52982144-A726AFA4-5EB0-406E-8086-4F1DD680F79CQ52991555-E4244284-C07C-4F59-BE42-3E6FE6C93E2AQ53061964-E5EBEE92-F626-4B32-98AF-06E038142977Q53063708-431221B9-D557-4C53-90A2-4EA594F88ABAQ53116215-CB79FB7E-0DD8-46F8-BA06-A13105778708Q53123911-4DC47654-6D7B-477E-A947-414658B8A665Q53136090-259C7492-4C80-4665-9EE7-96C717DFD28FQ58998353-4CF994FD-709F-45CA-A573-D8FF71B7F8DA
P2860
Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Clinical significance of metab ...... ut extranodal site involvement
@ast
Clinical significance of metab ...... ut extranodal site involvement
@en
type
label
Clinical significance of metab ...... ut extranodal site involvement
@ast
Clinical significance of metab ...... ut extranodal site involvement
@en
prefLabel
Clinical significance of metab ...... ut extranodal site involvement
@ast
Clinical significance of metab ...... ut extranodal site involvement
@en
P2093
P2860
P1433
P1476
Clinical significance of metab ...... ut extranodal site involvement
@en
P2093
Dong-Seop Chung
Gyeong-Won Lee
Ho-Jin Shin
Ho-Sup Lee
Joo-Seop Chung
Moo-Kon Song
Sang-Min Lee
Seok-Mo Lee
Seong-Jang Kim
P2860
P304
P356
10.1007/S00277-011-1357-2
P577
2011-11-11T00:00:00Z